Editorial
Copyright ©The Author(s) 2025.
World J Clin Oncol. Mar 24, 2025; 16(3): 100361
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.100361
Figure 1
Figure 1 The application of molecular methodologies in lung cancer. CTCs: Circulating tumor cells; CEA: Carcinoembryonic antigen; ctDNA: Circulating tumor DNA; cRNA: Circulating RNA; PD-1/PD-L1: Programmed death-1 and its ligand; EGFR: Epidermal growth factor receptor; ALK: Anaplastic lymphoma kinase; ROS1: C-ROS proto-oncogene 1; CTLA-4: Cytotoxic T-lymphocyte-associated protein.